期刊文献+

替莫唑胺联合鞘内注射治疗术后复发的颅内恶性肿瘤临床观察 被引量:2

原文传递
导出
摘要 颅内肿瘤由于其特有的血脑屏障和特殊的端粒酶活性,以及大脑丰富的血管和供血导致颅内肿瘤血管内皮细胞生长因子受体(EGFR)高表达,普通的化疗药物无法透过血脑屏障,小分子的替莫唑胺进入颅内的血药浓度也仅能达到30%~40%,鞘内注射药物浓度过高也同样会导致中枢神经系统不可逆损伤,我们采用替莫唑胺联合鞘内注射治疗颅内肿瘤达到了比较理想的效果。
出处 《中国基层医药》 CAS 2013年第20期3177-3178,共2页 Chinese Journal of Primary Medicine and Pharmacy
  • 相关文献

参考文献10

  • 1Roberto Papait, Lorenzo Magrassi, Dorotea Rigamonti, et al. Temo- zolomide and carmustine cause large-scale heterochromatin reor- ganization in glioma ceils. Biochem Biophys Res Communi ,2009, 379(2) :434-439. 被引量:1
  • 2Payne M J, Pratap SE, Middleton MR. Temozolomide in the treat- ment of solid tumours: current results and rationale for dosing/ scheduling. Crit Rev Oncol Hemato1,2005,53 (3) :241-252. 被引量:1
  • 3Woll PJ, Judson I, Lee SM, et al. Temozolomide in adult patients with advanced soft tissue sarcoma: a phase II study of the EORTC soft tissue and bone sarcoma group. Eur J Cancer, 1999,35 ( 3 ) : 410-412. 被引量:1
  • 4毛明辉,闫洪法,刘德全,龚惠芸,张元利,张炜.鞘内注射甲氨蝶呤和地塞米松治疗小细胞肺癌脑转移[J].肿瘤防治杂志,2004,11(2):160-161. 被引量:1
  • 5Trog D, Yeghiazaryan K, Fountoulakis M, et al. Pro-invasive gene regulating effect of irradiation and combined temozolomide-radia- tion treatment on surviving human malignant glioma cells. Eur J Pharmacol,2006,542( 1/3 ) :8-15. 被引量:1
  • 6毛明辉,闫洪法,龚惠芸,张元利,何儒鸿,张炜.甲氨喋呤鞘内注射治疗脑胶质瘤的疗效观察[J].临床神经病学杂志,2003,16(1):50-51. 被引量:1
  • 7潘峰,周东风,张慈伟,等.阿糖胞苷与地塞米松联合诱导Jur-kat细胞凋亡的协周效应.实用儿科杂志,201l,26(3):166-168. 被引量:1
  • 8Zhang YH, Yue ZJ, Zhang H, et al. Temozolomide/PLGA mierop- articles plus vatalanib inhibits tumor growth and angiogenesis in an orthotopic glioma model. Eur J Pharm Biopharm, 2010, 76 (3) :371-375. 被引量:1
  • 9Verger E, Gil M, YaYa R, et al. Temozolomide and concomitant whole brain radiotherapy in patients with brain metastases: A phase II randdomized trial. Int J Radiat Oncol Biol Phys,2005,61 (1) :185-191. 被引量:1
  • 10Yaman E, Buyukberber S, Benekli M, et al. Radiation induced early necrosis in patients with malignant gliomas receiving Temo- zolomide. Clin Neurol Neurosurg,2010,112 ( 8 ) :662-667. 被引量:1

二级参考文献8

同被引文献35

  • 1Massimino M, Giangaspero F, Gandola L, et al. Childhood medulloblastoma[J]. Cfit Rev Oncol Hematol, 2011,79 ( 10 ) : 65-83. 被引量:1
  • 2Koschmann C, Schmidt K J, Geyer JR, et al. Survival after recurrence of medulloblastoma in the contemporary em[J]. J Clin Oncol,2011, 29(Suppl) :2068. 被引量:1
  • 3Feinberg DA, Mark AS. Human brain motion and cerebralspinal fluid circulation demonstrated with MR velocity imaging [J]. Radiology, 1987,16 (27) :793-795. 被引量:1
  • 4Bossi A, Caracciolo V, Russo G, et al. Medulloblastoma from molecular pathology to therapy [J]. Clin Cancer Res,2008, 14 (4) : 971-976. 被引量:1
  • 5Gulino A, Air.ella A, Giangaspero F. Pathologiocal and molecular heterogeneity of medulloblastoma [ J ]. Cur Opin in Oncol, 2008, 20(6) :668-675. 被引量:1
  • 6Martin B, Nele S, Katja yon H, et al. Safety and toxicity of intrathecal liposomal cytarabine ( Depocyte ) in children and adolescents with recurrent or refractory brain tumors:a multi-institutional retrospective study[J]. Anti-Cancer Drugs ,2009,11 (9) :794-799. 被引量:1
  • 7Gilbar PJ. Intrathecal chemotherapy: potential for medication error [ J ]. Cancer Nursing,2013,15 (5) :465-476. 被引量:1
  • 8Sharon C, Martin G, Michael V,et al. Medulloblastoma in childhood: revisiting intrathecal therapy in infants and children [J]. Cancer Chemother Pharmacol,2010,6 ( 65 ) : 1173-1189. 被引量:1
  • 9杨文婷,徐建生,孙强,等.全反式维甲酸抑制转基因小鼠髓母细胞瘤生长机制研究[J].国际神经病学神经外科学杂志,2009,5(9):456-461. 被引量:1
  • 10Saito F, Hatano T, Hori M, et al. lateral and dorsal column hyperintensity on magnetic resonance imaging in a patient with myclopathy associated with intrathccal chemotherapy [J]. Case Rep Neurol,2013,5(5) : 110-115. 被引量:1

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部